The 4 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 600.00, with a high estimate of 640.00 and a low estimate of 550.00. The median estimate represents a +43.19% increase from the last price of 419.03.
The current consensus among 5 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.48
Reporting Date Feb 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.